Emerging combination endocrine therapies for advanced breast cancer

Breast J. 2018 Mar;24(2):214-215. doi: 10.1111/tbj.12876. Epub 2017 Jul 26.
No abstract available

Keywords: breast cancer; endocrine therapy; everolimus; palbociclib; ribociclib.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Androstadienes / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary
  • Breast Neoplasms / therapy*
  • Combined Modality Therapy / methods
  • Everolimus / administration & dosage*
  • Everolimus / adverse effects
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary
  • Receptor, ErbB-2 / metabolism
  • Receptors, Estrogen / metabolism

Substances

  • Androstadienes
  • Antineoplastic Agents
  • Receptors, Estrogen
  • Everolimus
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • exemestane